This topic contains a solution. Click here to go to the answer

Author Question: Selective serotonin reuptake inhibitors (SSRIs) are a. protagonists. b. ligands. c. synergists. ... (Read 63 times)

nevelica

  • Hero Member
  • *****
  • Posts: 563
Selective serotonin reuptake inhibitors (SSRIs) are
 
  a. protagonists.
  b. ligands.
  c. synergists.
  d. antagonists.
  e. agonists.

Question 2

A researcher asks individuals to participate in an experiment that causes arm muscle strain. The participants are instructed to use a provided muscle rub after the activity.
 
  One group gets a rub with active ingredients to reduce pain, whereas the other group gets a ____________ without active ingredients.
 
  a. placebo
  b. pseudotransmitter
  c. drug
  d. agonist
  e. ligand



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

sarahccccc

  • Sr. Member
  • ****
  • Posts: 318
Answer to Question 1

Answer: e. agonists.

Answer to Question 2

Answer: a. placebo




nevelica

  • Member
  • Posts: 563
Reply 2 on: Jun 22, 2018
:D TYSM


alvinum

  • Member
  • Posts: 317
Reply 3 on: Yesterday
Excellent

 

Did you know?

Multiple sclerosis is a condition wherein the body's nervous system is weakened by an autoimmune reaction that attacks the myelin sheaths of neurons.

Did you know?

About 3.2 billion people, nearly half the world population, are at risk for malaria. In 2015, there are about 214 million malaria cases and an estimated 438,000 malaria deaths.

Did you know?

Ether was used widely for surgeries but became less popular because of its flammability and its tendency to cause vomiting. In England, it was quickly replaced by chloroform, but this agent caused many deaths and lost popularity.

Did you know?

In 2012, nearly 24 milliion Americans, aged 12 and older, had abused an illicit drug, according to the National Institute on Drug Abuse (NIDA).

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library